Diagnostic performance of fusion (US/MRI guided) prostate biopsy: propensity score matched comparison of elastic versus rigid fusion system

2022 ◽  
Author(s):  
Mariaconsiglia Ferriero ◽  
Gabriele Tuderti ◽  
Gian Luca Muto ◽  
Cristian Fiori ◽  
Alfredo Maria Bove ◽  
...  
Keyword(s):  
Propensity Score ◽  
Prostate Biopsy ◽  
Diagnostic Performance ◽  
Fusion System ◽  
Mri Guided ◽  
Matched Comparison

Diagnostic performance of fusion (US/MRI guided) prostate biopsy: Propensity score matched comparison of elastic versus rigid fusion system

2021 ◽  
Vol 79 ◽  
pp. S1337-S1338
Author(s):  
M.C. Ferriero ◽  
C. Fiori ◽  
A.M. Bove ◽  
R. Mastroianni ◽  
G. Tuderti ◽  
...  
Keyword(s):  
Propensity Score ◽  
Prostate Biopsy ◽  
Diagnostic Performance ◽  
Fusion System ◽  
Mri Guided ◽  
Matched Comparison

scholarly journals Diagnostic performance of fusion (US/MRI guided) prostate biopsy: Comparison between elastic versus rigid fusion system

2020 ◽  
Vol 20 ◽  
pp. S60
Author(s):  
M. Ferriero ◽  
C. Fiori ◽  
A.M. Bove ◽  
R. Mastroianni ◽  
G. Tuderti ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Diagnostic Performance ◽  
Fusion System ◽  
Mri Guided

scholarly journals Diagnostic performance of fusion (US/MRI guided) prostate biopsy: Comparison between elastic versus rigid fusion system

2020 ◽  
Vol 19 ◽  
pp. e2303-e2304
Author(s):  
M.C. Ferriero ◽  
C. Fiori ◽  
A.M. Bove ◽  
R. Mastroianni ◽  
G. Tuderti ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Diagnostic Performance ◽  
Fusion System ◽  
Mri Guided

scholarly journals MP36-02 PERIPROCEDURAL AND DIAGNOSTIC OUTCOMES OF TRANSRECTAL VERSUS TRANSPERINEAL US/MRI GUIDED FUSION PROSTATE BIOPSY: MULTI-INSTITUTIONAL PROPENSITY SCORE MATCHED PAIR ANALYSIS

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Maria Consiglia Ferriero* ◽  
Rocco Simone Flammia ◽  
Marco Oderda ◽  
Valerio Forte ◽  
Alexandre Peltier ◽  
...  
Keyword(s):  
Propensity Score ◽  
Prostate Biopsy ◽  
Matched Pair ◽  
Matched Pair Analysis ◽  
Mri Guided ◽  
Pair Analysis ◽  
Diagnostic Outcomes

MP81-01 DIAGNOSTIC PERFORMANCE OF FUSION (US/MRI GUIDED) PROSTATE BIOPSY

2020 ◽  
Vol 203 ◽  
pp. e1235
Author(s):  
Mariaconsiglia Ferriero* ◽  
Cristian Fiori ◽  
Alfredo Bove ◽  
Riccardo Mastroianni ◽  
Gabriele Tuderti ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Diagnostic Performance ◽  
Mri Guided

844: MRI Guided Prostate Biopsy with Biological Image Acquisition and Targeting in a Standard 1.5T Scanner

2004 ◽  
Vol 171 (4S) ◽  
pp. 223-223
Author(s):  
Jonathan A. Coleman ◽  
Robert C. Susil ◽  
Axel Krieger ◽  
Peter L. Choyke ◽  
Betty Wise ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Image Acquisition ◽  
Mri Guided ◽  
Biological Image

scholarly journals A161 PREVALENCE OF FINANCIAL CONFLICTS OF INTEREST (FCOI) AMONG PROPENSITY-SCORE MATCHED RETROSPECTIVE STUDIES EVALUATING BIOLOGIC THERAPEUTICS FOR IBD

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 168-170
Author(s):  
K Elsolh ◽  
D Tham ◽  
M A Scaffidi ◽  
R Bansal ◽  
J Li ◽  
...  
Keyword(s):  
Propensity Score ◽  
Propensity Score Matching ◽  
Retrospective Studies ◽  
Conflicts Of Interest ◽  
Cochrane Library ◽  
High Burden ◽  
Real World Evidence ◽  
Full Text Retrieval ◽  
Financial Conflicts Of Interest ◽  
Matched Comparison

Abstract Background Inflammatory Bowel Disease (IBD) studies have commonly relied on real-world evidence to evaluate different therapies. An emerging idea has been the use of propensity score matching as a statistical method to account for baseline characteristics in IBD patients. In retrospective studies, propensity score matching of patients helps reduce treatment assignment bias and mimic the effects of randomization. Recently, propensity-score matching has become an important tool in IBD studies comparing biologic therapeutics. Biologic medications are among the highest-grossing drugs worldwide, and their pharmaceutical producers make considerable payments to physicians to market them. In spite of this, there is a lack of evidence examining the role of undue industry influence among propensity-score matched comparative studies evaluating biologic therapeutics for IBD. Aims Given the documented association between IBD biologics and FCOI, we hypothesize a high burden of FCOI in propensity-score matched studies. The aim of this study was to evaluate the prevalence of disclosed & undisclosed financial conflicts of Interest (FCOI) in propensity-score matched comparison studies evaluating biologics for IBD. Methods We developed & ran a librarian-reviewed systematic search on EMBASE, MEDLINE, and Cochrane Library databases for all propensity-score matched retrospective studies comparing biologics for the treatment of IBD. Full-text retrieval & screening was performed on all studies in duplicate. 16 articles were identified. Industry payments to authors were only considered FCOI if they were made by a company producing a biologic that was included in the comparison study. Disclosed FCOI were identified by authors’ interests disclosures in full-texts. Any undisclosed FCOI among US authors were identified using the Centre for Medicare and Medicaid Services (CMS) Open Payments Database, which collects industry payments to physicians. Results Based on a preliminary analysis of 16 studies, there was at least one author with a relevant FCOI in 14 (88%) of the 16 studies. 14 studies (88%) had at least one disclosed FCOI, while 6 studies (37.5%) had at least one undisclosed FCOI. Among studies with disclosed FCOI, a mean of 40.2% (SD = 23.4%) of authors/study reported FCOI. Among studies with undisclosed FCOI, a mean of 18.8% (SD = 7.0%) of authors/study reported FCOI. The total dollar value of FCOIs was $1,974,328.3. The median conflict dollar value was $5,576.6 (IQR: $321.6 to $36,394.9). Conclusions We found a high burden of undisclosed FCOI (37.5%) among authors of propensity-score matched studies evaluating IBD biologics. Given the potential for undue industry influence stemming from such payments, authors should ensure better transparency with industry relationships. Funding Agencies None

Donation After Circulatory Death Liver Transplantation: An in Depth Analysis and Propensity‐Score Matched Comparison

2021 ◽  
Author(s):  
Mark J. Hobeika ◽  
Ashish Saharia ◽  
Constance M. Mobley ◽  
Terri Menser ◽  
Duc T. Nguyen ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Propensity Score ◽  
Donation After Circulatory Death ◽  
Depth Analysis ◽  
Matched Comparison ◽  
Circulatory Death
Sign in / Sign up

Export Citation Format

Share Document